Johnson & Johnson

JNJ
Delayed Nyse - 10/18 10:00:19 pm
127.7USD
-6.22%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e)
Sales 81 581 82 226
EBITDA 28 104 29 439
Operating profit (EBIT) 21 175 25 622
Pre-Tax Profit (EBT) 17 999 22 476
Net income 15 297 19 665
P/E ratio 23,0x 17,7x
EPS ( $ ) 5,61 7,20
Dividend per Share ( $ ) 3,54 3,76
Yield 2,74% 2,94%
Reference price ( $ ) 129,050 127,700
Announcement Date 01/22/2019
11:40am
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e)
Debt 7 997 7 881
Finance - -
Operating income (EBITDA) 28 104 29 439
Leverage
(Debt/EBITDA)
0,28x 0,27x
Capital Expenditure 3 670 3 576
Free Cash Flow (FCF) 18 531 18 752
Book Value Per Share (BVPS) ( $ ) 22,4 23,7
Cash Flow per Share ( $ ) 8,14 8,81
Announcement Date 01/22/2019
11:40am
-
Balance Sheet Analysis
Financial Ratios
Size 2019e 2020e
Capitalization 337 021 M $ -
Entreprise Value (EV) 344 902 M $ 335 189 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 17,7x 16,6x
Capitalization / Revenue 4,10x 3,95x
EV / Revenue 4,19x 4,04x
EV / EBITDA 11,7x 10,6x
Yield (DPS / Price) 2,94% 3,14%
Price to book (Price / BVPS) 5,38x 4,91x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 31,2% 32,9%
Operating Leverage (Delta EBIT / Delta Sales) 26,6x 2,54x
Net Margin (Net Profit / Revenue) 23,9% 24,5%
ROA (Net Profit / Asset) 13,5% 13,7%
ROE (Net Profit / Equities) 34,2% 32,8%
Rate of Dividend 52,2% 52,1%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   4,35% 4,32%
Cash Flow / Sales 28,3% 29,5%
Capital Intensity (Assets / Sales) 1,77x 1,79x
Financial Leverage (Net Debt / EBITDA) 0,27x -
Price Earning Ratio
BNA & Dividende